14 Jan 2021 09:49
Oncimmune Holdings plc
Β
("Oncimmune" or the "Company")
Β
PDMR Dealing
Β
Oncimmune Holdings plc (AIM: ONC.L),Β the leading global immunodiagnostics group, has been notified on 13 January 2021 that Genostics Company Limited ("Genostics"), a Person Closely Associated ("PCA") (as that term is defined in the EU Market Abuse Regulation ("MAR")) with Dr Cheung To, a Non-Executive Director of the Company, has sold ordinary shares of Β£0.01 each in the Company ("Ordinary Shares") as follows:
Β
Date | No Ordinary Shares | Price (Β£) |
11 December 2020 | 10,000 | 1.65 |
14 December 2020 | 30,000 | 1.675 |
21 December 2020 | 5,000 | 1.70 |
5 January 2021 | 50,000 | 1.70 |
5 January 2021 | 50,000 | 1.75 |
8 January 2021 | 10,000 | 1.85 |
11 January 2021 | 40,000 | 1.85 |
Total | 195,000 |
Β
Following this transaction, Genostics has a total interest in the Company of 6,215,256 Ordinary Shares, representing approximately 9.8 per cent. of the Company's issued Ordinary Share capital.Β Β
Β
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of MAR.
Β
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Β
Β | Details of the person discharging managerial responsibilities / person closely associated Β | ||||
a) Β | Name Β | Genostics Company Limited | |||
2 Β | Reason for the notification | ||||
a) Β | Position/status Β | PCA of Dr Cheung To, Non-Executive Director of the Company | |||
b) Β | Initial notification /Amendment Β | Initial notification | |||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | ||||
a) Β | Name Β | Oncimmune Holdings plc | |||
b) Β | LEI | 213800HCYIWT6YPI1I02Β | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.65 | 10,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 11 December 2020 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.675 | 30,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 14 December 2020 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.70 | 5,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 21 December 2020 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.70 | 50,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 5 January 2021 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.75 | 50,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 5 January 2021 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.85 | 10,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 8 January 2021 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of Β£0.01 each Β | |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b) Β | Nature of the transaction Β | Disposal of shares | |||
c) Β | Price(s) and volume(s) | ||||
Price | Volume | ||||
Β£1.85 | 40,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e) Β | Date of the transaction Β | 11 January 2021 | |||
f) Β | Place of the transaction | London stock exchange, AIM | |||
Β
Β
For further information:
Β
Oncimmune Holdings plc
Ron Kirschner, General Counsel and Company Secretary
contact@oncimmune.comΒ Β
Β
Follow the stocks